Patent hemostasis of radial artery: Comparison of two methods

Table 2 Procedural data of the study population

Procedural data	Control group (conventional hemostasis) (n = 147)	Oximetry – plethysmography group (n = 152)	P value
PCI, n (%)	44 (29.9)	58 (38.2)	0.1341
Primary PCI, n (%)	12 (8.2)	15 (9.9)	0.6071
Heparin dose, median (IQR)	5000 (5000-7000)	5000 (5000-7000)	0.1132
INR, mean ± SD	1.1 ± 0.3)	1.1 ± 0.3)	0.9583
Significant coronary artery lesions, n (%)
Left anterior descending artery	32 (21.8)	36 (23.7)	0.6931
Circumflex	10 (6.8)	12 (7.9)	0.7181
Right coronary artery	17 (11.6)	20 (13.2)	0.6761
Number of vessels4, n (%)			0.7073
PCI in 1 vessel (%)	35 (81.4)	50 (87.7)
PCI >1 vessels (%)	8 (18.6)	7 (12.3)
Hemostatic device			0.2231
Air chamber, n (%)	80 (54.4)	72 (47.4)
Valve with pressure plate, n (%)	67 (45.6)	80 (52.6)
Right hand, n (%)	104 (70.7)	115 (75.7)	0.3621
Left hand, n (%)	43 (29.3)	37 (24.3)
Puncture attempts, median (IQR)	1 (1-1)	1 (1-1)	0.3542
Puncture duration (min), median (IQR)	2.25 (1.42-3.3)	2.22 (1.44-3.37)	0.6602
Procedure time (min), median (IQR)	13 (8.4-27.3)	13.8 (9.2-26.9)	0.4482
Fluoro time (min), median (IQR)	3.1 (1.3-9.1)	3.4 (1.4-7.7)	0.6632
Sheath, n (%)			0.2573
5F	74 (50.3)	70 (46.1)
6F	73 (49.7)	79 (52.0)
7F	0 (0.0)	3 (2.0)
Patent hemostasis, n (%)	94 (68.1)	125 (82.2)	0.0051

¹Pearson’s χ².

²Mann-Whitney test.

³Fisher’s exact test.

⁴For those who underwent percutaneous coronary intervention.

INR: International normalized ratio; IQR: Interquartile range; PCI: Percutaneous coronary intervention.